BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24778569)

  • 1. Hair depigmentation and dermatitis - an unexpected presentation of cystic fibrosis.
    Milankov O; Savic R; Tosic J
    Balkan J Med Genet; 2013 Dec; 16(2):81-4. PubMed ID: 24778569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray hair and acrodermatitis enteropathica-like dermatitis: an unexpected presentation of cystic fibrosis.
    Dalgic B; Egritas O
    Eur J Pediatr; 2011 Oct; 170(10):1305-8. PubMed ID: 21424670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatitis as a presenting sign of cystic fibrosis.
    Darmstadt GL; Schmidt CP; Wechsler DS; Tunnessen WW; Rosenstein BJ
    Arch Dermatol; 1992 Oct; 128(10):1358-64. PubMed ID: 1417024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of an infant with nutritional deficiency dermatitis as the initial manifestation of cystic fibrosis.
    Stojković A; Radlović N; Vuletić B; Nestorović B; Leković Z; Obradović S; Vujić A
    Srp Arh Celok Lek; 2013; 141(11-12):810-3. PubMed ID: 24502104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous manifestations of cystic fibrosis in an infant: acrodermatitis enteropathica and gray hair].
    Yarmuch GP; Chaparro RX; Fischer SC
    Rev Chil Pediatr; 2015; 86(1):52-5. PubMed ID: 26223399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Presentation of Cystic Fibrosis in An Infant.
    Sahoo B; Jain MK; Mishra R; Patnaik S
    Indian J Dermatol; 2022; 67(3):287-289. PubMed ID: 36386118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis presenting with dermatitis.
    Wenk KS; Higgins KB; Greer KE
    Arch Dermatol; 2010 Feb; 146(2):171-4. PubMed ID: 20157028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early severe anemia as the first sign of cystic fibrosis.
    Sismanlar T; Aslan AT; Köse M; Pekcan S; Ezgü FS; Budakoğlu Iİ; Yenicesu İ
    Eur J Pediatr; 2016 Sep; 175(9):1157-1163. PubMed ID: 27496146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.
    Kerem E; Rave-Harel N; Augarten A; Madgar I; Nissim-Rafinia M; Yahav Y; Goshen R; Bentur L; Rivlin J; Aviram M; Genem A; Chiba-Falek O; Kraemer MR; Simon A; Branski D; Kerem B
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1914-20. PubMed ID: 9196095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis--case report and review of the literature.
    Crone J; Huber WD; Eichler I; Granditsch G
    Eur J Pediatr; 2002 Sep; 161(9):475-8. PubMed ID: 12200605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse dermatitis: An unexpected initial presentation of cystic fibrosis.
    Lovett A; Kokta V; Maari C
    J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S1-4. PubMed ID: 18191689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CFTR mutations in a Korean infant with cystic fibrosis and pancreatic insufficiency.
    Choe YJ; Ko JS; Seo JK; Han JJ; Shim JO; Koh YY; Lee R; Ki CS; Kim JW; Kim JH
    J Korean Med Sci; 2010 Jan; 25(1):163-5. PubMed ID: 20052365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K and the management of patients with cystic fibrosis.
    Durie PR
    CMAJ; 1994 Oct; 151(7):933-6. PubMed ID: 7922929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy.
    Giannakopoulos A; Katelaris A; Noni M; Karakonstantakis T; Kanaka-Gantenbein C; Doudounakis S
    Eur J Pediatr; 2018 May; 177(5):775-779. PubMed ID: 29487998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
    Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
    J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis presenting as recurrent pancreatitis in a young child with a normal sweat test and pancreas divisum: a case report.
    Conklin L; Zeitlin PL; Cuffari C
    J Med Case Rep; 2008 May; 2():176. PubMed ID: 18501000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier?
    Steinraths M; Vallance HD; Davidson AG
    Can Fam Physician; 2008 Jun; 54(6):877-83. PubMed ID: 18556497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent morbidity and mortality of protein calorie malnutrition in young infants with CF.
    Abman SH; Accurso FJ; Bowman CM
    J Pediatr Gastroenterol Nutr; 1986; 5(3):393-6. PubMed ID: 3088250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.